These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20840671)

  • 61. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.
    Ooi A; Zen Y; Ninomiya I; Tajiri R; Suzuki S; Kobayashi H; Imoto I; Dobashi Y
    Pathol Int; 2010 Jun; 60(6):466-71. PubMed ID: 20518902
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
    Marx AH; Zielinski M; Kowitz CM; Dancau AM; Thieltges S; Simon R; Choschzick M; Yekebas E; Kaifi JT; Mirlacher M; Atanackovic D; Brümmendorf TH; Fiedler W; Bokemeyer C; Izbicki JR; Sauter G
    Histopathology; 2010 Sep; 57(3):418-26. PubMed ID: 20840671
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.